The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk of significant functional impairment across cancer diagnosis and care continuum.
 
Ann Marie Flores
No Relationships to Disclose
 
Mitisha Shah
Employment - Medtronic (I)
Travel, Accommodations, Expenses - Medtronic (I)
 
Katy Bedjeti
Employment - Children's Hospital of Wisconsin (I)
 
Patricia D. Franklin
Research Funding - Deputy Inc research award, U. of Washington DSMB)
(OPTIONAL) Uncompensated Relationships - Member, Arthritis Foundation Scientific Advisory Committee
 
John Devin Peipert
Consulting or Advisory Role - BMS (Inst); Clovis Oncology (Inst); Day One Biopharmaceuticals; FACIT.org; Pfizer (Inst)
Research Funding - Pfizer (Inst); Veloxis (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Sofia F. Garcia
No Relationships to Disclose
 
Nicola Lancki
No Relationships to Disclose
 
Kimberly A. Webster
Stock and Other Ownership Interests - FACIT.org (I)
Consulting or Advisory Role - Abbvie; Pfizer; Astellas Pharma, Novartis; Bristol-Myers Squibb, Ipsen, Celcuity, Immunogen, Fulcrum Therapeutics (I)
Research Funding - Novartis, Ipsen, Pfizer, PledPharma, Bristol-Myers Squibb, Abbvie, Clovis (I)
Patents, Royalties, Other Intellectual Property - FACIT.org (I)
 
Mary Lillian O'Connor
No Relationships to Disclose
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Celcuity; Fulcrum Therapeutics; Immunogen; Ipsen; Novartis; Pfizer
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst); PledPharma (Inst)